High Background Signal Research Articles

Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces

Phage-displayed random peptide libraries are widely used for identifying peptide interactions with proteins and other substrates. Selection of peptide ligands involves iterative rounds of affinity enrichment. The binding properties of the selected phage clones are routinely tested using immunoassay after propagation to high titre in a bacterial host and precipitation using polyethylene glycol (PEG) and high salt concentration. These immunoassays can suffer from low sensitivity and high background signals. Polysorbate 20 (Tween® 20) is a non-ionic detergent commonly used in immunoassay washing buffers to reduce non-specific binding, and is also used as a blocking reagent. We have observed that Tween 20 enhances non-specific M13 library phage binding in a peptide-independent manner. Other non-ionic detergents were also found to promote significant, dose-dependent non-specific phage binding in ELISA. This effect was not observed for assays using phage concentrated by ultracentrifugation, suggesting that interactions occur between detergents and the PEG-precipitated phage, irrespective of the displayed peptide motif. This artefact may impact on successful affinity selection of peptides from phage-display libraries. We propose alternative methods for screening phage libraries for identifying binding interactions with target ligands.

Feasibility of polymer gel dosimetry measurements in a dynamic porcine lung phantom

A dynamic ex-vivo porcine lung phantom combined with polymer gel dosimetry is tested as a new tool to validate modern adaptive radiotherapy techniques (e.g. gating or tracking). The gel was inserted into the lung via a latex balloon to simulate a tumor. After irradiation, the location of the dose maximum was verified, however, the dose was higher than planned and a high background signal was seen. Potential reasons for this finding are the nonstandard conditions of gel handling. These conditions were systematically studied. Besides temperature, the material of the balloon seems to be of special importance. The results identify open issues that have to be addressed in future studies.

Exponential amplification of DNA with very low background using graphene oxide and single-stranded binding protein to suppress non-specific amplification

The high background signal caused by non-specific amplification (NSA) is a serious issue when using the conventional exponential amplification reaction (EXPAR). We describe a novel method of suppressing NSA using 10 mg L−1 graphene oxide (GO) to prevent non-specific binding of DNA polymerase to the template, resulting in ultra-low background. A side effect of the use of GO is the slow release of ssDNA from the GO surface, with the positive signal decreasing accordingly. The problem of low signal intensity is addressed by applying a 2 μM solution of single-stranded binding protein (SSB) to accelerate the release of template for EXPAR. The use of GO and SSB in EXPAR can substantially suppress NSA, but it does not compromise the performance of the quantification step. The improved EXPAR presented here can detect concentration as low as 5 aM of trigger, which is approximately four orders of magnitude lower than that of conventional EXPAR under the same experimental conditions.

Small RNA existed in commercial reverse transcriptase: primary evidence of functional small RNAs.

MicroRNAs (miRNAs) are small RNA molecules (approximately 22 nucleotides long) that take part in the post-transcriptional regulation of gene expression (Chen and Rajewsky, 2007). Thousands of these RNAs have been reported since their discovery. These small molecules have been shown to play an important regulatory role in a wide range of biological and pathological processes (Brennecke et al., 2003; Cuellar and McManus, 2005; Lim et al., 2005). Recently, miRNAs have been found in serum, plasma, urine and other bodily fluids (Chen et al., 2008; Weber et al., 2010). Interestingly, the expression profiles of these extracellular miRNAs are correlated with various diseases; they may be used as biomarkers in diagnosing and monitoring human diseases (Lu et al., 2005). Various techniques have emerged to quantify miRNAs. MiRNA expression can be quantified by two-step RT-qPCR, which can provide relative quantification (Chen et al., 2005). MiRNAs can also be hybridized onmicroarrays, slides or chips with probes for hundreds of miRNA targets, and relative miRNA levels can be determined in different samples (Shingara et al., 2005).High-throughput sequencingmethodscanalsobe used to profile miRNAs (Buermans et al., 2010). RT-qPCR is usually performed as a standard for accuracy and sensitivity during the typical procedure to determine the miRNA expressionprofile. For this reason, the quality of theRT-qPCRsystem is closely related to the final determination and result. We were surprised to find that the background of certain miRNAs was very high in the RT-qPCR results, even in notemplate-controls during practice trials. By considering the high specificity of the stem-loop RT primers, we studied the origin of this high background in miRNA RT-qPCR and found that commercial avian myeloblastosis virus (AMV) reverse transcriptase may contain miRNAs. In practice, DEPC-treated water or ultrapure water (Invitrogen) served as no-template-controls for miRNA quantitation. However, certain miRNAs (for example, Let-7a, miR-16, miR-26a, and miR-191 in this study) exhibited high background signals in these no-template-controls when AMV reverse transcriptase was used (Fig. 1A). DNA sequencing showed that the PCR products were correct (data not shown). We tried two other commercial AMV reverse SMALL RNA IN REVERSE TRANSCRIPTASE: TOO SMALL TO BE FOUND

Rapid and Sensitive Detection of p53 Based on DNA-Protein Binding Interactions Using Silver Nanoparticle Films and Microwave Heating

Tumor detection can be carried out via the detection of proteins, such as p53, which is known to play vital role in more than 50% of all cancers affecting humans. Early diagnosis of tumor detection can be achieved by decreasing the lower detection limit of p53 bioassays. Microwave-accelerated bioassay (MAB) technique, which is based on the use of circular bioassay platforms in combination with microwave heating, is employed for the rapid and sensitive detection of p53 protein. Direct sandwich ELISA was constructed on our circular bioassay platforms based on DNA-protein binding interactions. Colorimetric and fluorescence based detection methods were used for room temperature bioassay (control bioassay; total bioassay time is 27 hours) and bioassay using microwave heating (i.e., the MAB technique; total bioassay time is 10 minutes). In the colorimetric based detection, a very high background signal due to the non-specific binding of proteins for the bioassay carried out at room temperature and a LLOD of 0.01 ng/mL for p53 was observed using the MAB technique. The LLOD for the fluorescence-based detection using the MAB technique was found to be 0.01 ng/mL. The use of circular bioassay platforms in the MAB technique results in microwave-induced temperature gradient, where the specific protein binding interactions are significantly accelerated; thereby reducing the background signal and the lower limit of detection of p53 protein.

Optimal point spread function design for 3D imaging.

To extract from an image of a single nanoscale object maximum physical information about its position, we propose and demonstrate a framework for pupil-plane modulation for 3D imaging applications requiring precise localization, including single-particle tracking and superresolution microscopy. The method is based on maximizing the information content of the system, by formulating and solving the appropriate optimization problem--finding the pupil-plane phase pattern that would yield a point spread function (PSF) with optimal Fisher information properties. We use our method to generate and experimentally demonstrate two example PSFs: one optimized for 3D localization precision over a 3 μm depth of field, and another with an unprecedented 5 μm depth of field, both designed to perform under physically common conditions of high background signals.

Aqueous two-phase systems enable multiplexing of homogeneous immunoassays.

Quantitative measurement of protein biomarkers is critical for biomarker validation and early disease detection. Current multiplex immunoassays are time consuming costly and can suffer from low accuracy. For example, multiplex ELISAs require multiple, tedious, washing and blocking steps. Moreover, they suffer from nonspecific antibody cross-reactions, leading to high background and false-positive signals. Here, we show that co-localizing antibody-bead pairs in an aqueous two-phase system (ATPS) enables multiplexing of sensitive, no-wash, homogeneous assays, while preventing nonspecific antibody cross-reactions. Our cross-reaction-free, multiplex assay can simultaneously detect picomolar concentrations of four protein biomarkers ((C-X-C motif) ligand 10 (CXCL10), CXCL9, interleukin (IL)-8 and IL-6) in cell supernatants using a single assay well. The potential clinical utility of the assay is demonstrated by detecting diagnostic biomarkers (CXCL10 and CXCL9) in plasma from 88 patients at the onset of the clinical symptoms of chronic graft-versus-host disease (GVHD).

A Mutated Anti-CA19-9 scFv-Fc for Positron Emission Tomography of Human Pancreatic Cancer Xenografts

Intact antibodies have a long serum persistence resulting in high background signal that inhibits their direct translation as imaging agents. Engineering of antibody fragments through the introduction of mutations in the fragment crystallizable (Fc) region can dramatically reduce serum persistence. We sought to develop a Fc-mutated, anti-CA19-9 antibody fragment (anti-CA 19-9 scFv-Fc H310A) to provide micro-positron emission tomography (microPET) imaging of pancreatic cancer xenografts. The anti-CA19-9 scFv-Fc H310A was successfully expressed and purified. Biochemical characterization included size exclusion chromatography, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), Western blot, and flow cytometry. The antibody fragment was labeled with iodine-124 ((124)I) and injected into mice containing human pancreatic cancer xenografts. MicroPET/CT images were then obtained. Blood, organ, and tumor radioactivity was measured and expressed as the percent of injected dose per gram of tissue (%ID/g). Biochemical characterization was consistent with the creation of a 105kD dimer containing a human Fc region. Flow cytometry demonstrated antigen-specific binding, and cell-based ELISA further established a dissociation constant (K D) of 10.7nM. (124)I-labeled scFv-Fc H310A localized to the antigen-positive tumor xenografts as detected by microPET. Objective confirmation of targeting was demonstrated by higher %ID/g in the antigen-positive tumor compared to the blood, antigen-negative tumor, and liver. We successfully engineered and produced an anti-CA19-9 scFv-Fc H310A antibody fragment that retains similar affinity when compared to the parental intact murine antibody. Additionally, our engineered and mutated fragment exhibited antigen-specific microPET imaging of both subcutaneous and orthotopic pancreatic cancer xenografts at early time points secondary to decreased serum half-life.

Cleaning Up Western Blot Signals From Immunoprecipitated Samples Using Alternative Detection Methods

High background signal is a common problem experienced when detecting proteins isolated through immunoprecipitation (IP) by Western blotting (WB). The most frequent cause of high background is signal interference from the heavy and light chain fragments of the denatured immunoprecipitating (or capture) antibody ' by-products of IP labeled by species-specific secondary antibodies at the WB stage. Here we comment on alternative methods for the detection of immunoprecipitated proteins by WB that avoid labeling of the heavy and light chain to varying extents. Certain methods have been described elsewhere (1), however, their use remains less widespread than traditional detection methods despite offering the researcher considerable advantages.

Fluorogen-Activating scFv Biosensors Target Surface Markers on Live Cells Via Streptavidin or Single-Chain Avidin

Fluorescence biosensors are indispensable tools for understanding protein behavior and function in cells. Recent advancements utilize fluorogen-activating-proteins (FAPs) that form complexes with small organic molecules (fluorogens) and result in their fluorescence activation. The technology has found multiple uses in protein discovery applications; however, the current method of detection requires the expression of FAPs as gene fusion tags in cells-a process that is time- and labor-intensive. In this report, we present an alternate method that utilizes FAPs as affinity reagents. Accordingly, we isolated soluble reagents based on FAP fusions with streptavidin (Strep) or avidin proteins, both highly selective for biotin. When tested in vitro, the reagents displayed bi-functional activity, fluorogen activation, and biotin affinity. For live-cell protein discovery, surface targets were biotinylated via biotin-tagged immunoglobulins or a genetically encoded biotin acceptor peptide. As a result, when the cells were labeled with FAP-Strep or FAP-avidin reagent, the in vivo fluorescence measurements indicated high target specificity, minimal background, and bright signal detection. In summary, we present a novel FAP reagent platform that offers a rapid and efficient approach for cell surface protein detection.

Methods for Processing Microarray Data

Quality control must be maintained at every step of a microarray experiment, from RNA isolation through statistical evaluation. Here we provide suggestions for analyzing microarray data. Because the utility of the results depends directly on the design of the experiment, the first critical step is to ensure that the experiment can be properly analyzed and interpreted. What is the biological question? What is the best way to perform the experiment? How many replicates will be required to obtain the desired statistical resolution? Next, the samples must be prepared, pass quality controls for integrity and representation, and be hybridized and scanned. Also, slides with defects, missing data, high background, or weak signal must be rejected. Data from individual slides must be normalized and combined so that the data are as free of systematic bias as possible. The third phase is to apply statistical filters and tests to the data to determine genes (1) expressed above background, (2) whose expression level changes in different samples, and (3) whose RNA-processing patterns or protein associations change. Next, a subset of the data should be validated by an alternative method, such as reverse transcription-polymerase chain reaction (RT-PCR). Provided that this endorses the general conclusions of the array analysis, gene sets whose expression, splicing, polyadenylation, protein binding, etc. change in different samples can be classified with respect to function, sequence motif properties, as well as other categories to extract hypotheses for their biological roles and regulatory logic.

Functional Magnetic Resonance Imaging of the Lung

Beyond being a substitute for X-ray, computed tomography, and scintigraphy, magnetic resonance imaging (MRI) inherently combines morphologic and functional information more than any other technology. Lung perfusion: The most established method is first-pass contrast-enhanced imaging with bolus injection of gadolinium chelates and time-resolved gradient-echo (GRE) sequences covering the whole lung (1 volume/s). Images are evaluated visually or semiquantitatively, while absolute quantification remains challenging due to the nonlinear relation of T1-shortening and contrast material concentration. Noncontrast-enhanced perfusion imaging is still experimental, either based on arterial spin labeling or Fourier decomposition. The latter is used to separate high- and low-frequency oscillations of lung signal related to the effects of pulsatile blood flow. Lung ventilation: Using contrast-enhanced first-pass perfusion, lung ventilation deficits are indirectly identified by hypoxic vasoconstriction. More direct but still experimental approaches use either inhalation of pure oxygen, an aerosolized contrast agent, or hyperpolarized noble gases. Fourier decomposition MRI based on the low-frequency lung signal oscillation allows for visualization of ventilation without any contrast agent. Respiratory mechanics: Time-resolved series with high background signal such as GRE or steady-state free precession visualize the movement of chest wall, diaphragm, mediastinum, lung tissue, tracheal wall, and tumor. The assessment of volume changes allows drawing conclusions on regional ventilation. With this arsenal of functional imaging capabilities at high spatial and temporal resolution but without radiation burden, MRI will find its role in regional functional lung analysis and will therefore overcome the sensitivity of global lung function analysis for repeated short-term treatment monitoring.

Comparison and Reappraisal of Carbon Electrodes for the Voltammetric Detection of Dopamine

The electro-oxidation of dopamine (DA) is investigated on the unmodified surfaces of five different classes of carbon electrodes: glassy carbon (GC), oxygen-terminated polycrystalline boron-doped diamond (pBDD), edge plane pyrolytic graphite (EPPG), basal plane pyrolytic graphite (BPPG), and the basal surface of highly oriented pyrolytic graphite (HOPG), encompassing five distinct grades with step edge density and coverage varying by more than 2 orders of magnitude. Surfaces were prepared carefully and characterized by a range of techniques, including atomic force microscopy (AFM), field emission scanning electron microscopy (FE-SEM), and Raman spectroscopy. Although pBDD was found to be the least susceptible to surface fouling (even at relatively high DA concentrations), the reaction showed sluggish kinetics on this electrode. In contrast, DA electro-oxidation at pristine basal plane HOPG at concentrations ≤100 μM in 0.15 M PBS, pH 7.2, showed fast kinetics and only minor susceptibility toward surface fouling from DA byproducts, although the extent of HOPG surface contamination by oxidation products increased substantially at higher concentrations (with the response similar on all grades, irrespective of step edge coverage). EPPG also showed a fast response, with little indication of passivation with repeated voltammetric cycling but a relatively high background signal due to the high capacitance of this graphite surface termination. Of all five carbon electrode types, freshly cleaved basal plane HOPG showed the clearest signal (distinct from the background) at low concentrations of DA (<10 μM) as a consequence of the low capacitance. Studies of the electrochemical oxidation of DA in the presence of the common interferents ascorbic acid (AA) and serotonin (5-HT), of relevance to neurochemical analysis, showed that the signals for DA were still clearly and easily resolved at basal plane HOPG surfaces. In the presence of AA, repetitive voltammetry caused products of AA electro-oxidation to adsorb onto the HOPG surface, forming a permselective film that allowed the electrochemical oxidation of DA to proceed unimpeded, while greatly inhibiting the electrochemical response of AA itself. The studies presented provide conclusive evidence that the pristine surface of basal plane HOPG is highly active for the detection of DA, irrespective of the step edge density and method of cleavage, and adds to a growing body of evidence that the basal plane of HOPG is a much more active electrode for many classes of electrode reactions than previously believed.

Determination of cysteine and glutathione based on the inhibition of the dinuclear Cu(II)-catalyzed luminol–H2O2 chemiluminescence reaction

The catalyzed luminol chemiluminescent reaction has received a great amount of attention because of its high sensitivity and low background signal which make the reaction an attractive analytical chemistry tool. The present study, introduces the beneficial catalytic effects of dinuclear Cu(II) complex [Cu2L2(TAE)]X2, where TAE=tetraacetylethane; L=N,N’-dibenzylethylenediamine and X=ClO4 on the luminol chemiluminescent reaction as a novel probe for the determination of glutathione (GSH) and L-cysteine (CySH) in human serum and urine. The [Cu2L2(TAE)]X2 has exhibited highly efficient catalytic activity of luminol CL as an artificial peroxidase model at pH as low as 7.5 in water in the presence of H2O2⋅GSH and CySH can induce a sharp decrease in CL intensity from the [Cu2L2(TAE)]X2-catalyzed luminol system. Under the selected experimental conditions, a linear relationship was obtained between the CL intensity and the concentrations of GSH and CySH in the range of 1.0×10−7–1.0×10−4M, with detection limits (S/N=3) of 2.7×10−8 and 6.8×10−8M and RSD<4.2% (n=7) for GSH and CySH, respectively.

IRFP is a sensitive marker for cell number and tumor growth in high-throughput systems

GFP and luciferase are used extensively as markers both in vitro and in vivo although both have limitations. The utility of GFP fluorescence is restricted by high background signal and poor tissue penetrance. Luciferase throughput is limited in vitro by the requirement for cell lysis, while in vivo, luciferase readout is complicated by the need for substrate injection and the dependence on endogenous ATP. Here we show that near-infrared fluorescent protein in combination with widely available near-infrared scanners overcomes these obstacles and allows for the accurate determination of cell number in vitro and tumor growth in vivo in a high-throughput manner and at negligible per-well costs. This system represents a significant advance in tracking cell proliferation in tissue culture as well as in animals, with widespread applications in cell biology.

Optically Modulatable Blue Fluorescent Proteins

Blue fluorescent proteins (BFPs) offer visualization of protein location and behavior, but often suffer from high autofluorescent background and poor signal discrimination. Through dual-laser excitation of bright and photoinduced dark states, mutations to the residues surrounding the BFP chromophore enable long-wavelength optical modulation of BFP emission. Such dark state engineering enables violet-excited blue emission to be increased upon lower energy, green coillumination. Turning this green coillumination on and off at a specific frequency dynamically modulates collected blue fluorescence without generating additional background. Interpreted as transient photoconversion between neutral cis and anionic trans chromophoric forms, mutations tune photoisomerization and ground state tautomerizations to enable long-wavelength depopulation of the millisecond-lived, spectrally shifted dark states. Single mutations to the tyrosine-based blue fluorescent protein T203V/S205V exhibit enhanced modulation depth and varied frequency. Importantly, analogous single point mutations in the nonmodulatable BFP, mKalama1, creates a modulatable variant. Building modulatable BFPs offers opportunities for improved BFP signal discrimination vs background, greatly enhancing their utility.

Development of a liquid chromatography/tandem mass spectrometry method to investigate the presence of biomarkers of DNA damage in urine related to red meat consumption and risk of colorectal cancer

The consumption of red meat is known to enhance the endogenous formation of N-nitroso compounds (NOCs), which are potent carcinogens. DNA damage related to NOCs, and hence red meat, has been detected in colorectal cells and in blood. We proposed to extend previous studies to a non-invasive approach for the detection of O(6)-carboxymethylguanine (O(6)CMG) and O(6)-carboxymethyl-2'-deoxyguanosine (O(6)CMdG) in urine in relation to red meat intake using liquid chromatography/tandem mass spectrometry (LC/MS/MS). The presence of the adduct in urine samples either as the free base or as 2'-deoxynucleoside could help in determining the repair mechanism involved when such lesions are produced. A non-invasive assessment of DNA adducts could also allow for large-scale analyses in the population and cancer prevention dietary strategies. An LC/MS/MS method for the quantitation of O(6)CMG and O(6)CMdG was developed. Urine samples collected from healthy volunteers on red meat and vegetarian diets were analysed either by direct injection or after purification by solid-phase extraction (SPE). A separate LC/MS/MS method for O(6)-methylguanine (O(6)MeG) and O(6)-methyl-2'-deoxyguanosine (O(6)MedG), which are possible hydrolysis products forming during the sample pre-treatment, was also developed. The developed LC/MS/MS method allowed the simultaneous measurement of O(6)CMG and O(6)CMdG. The limits of detection (LODs) were 0.38 ng/mL for O(6)CMG and 0.18 ng/mL for O(6)CMdG. The direct injection analysis of the clinical samples showed low sensitivity due to high background signal that was improved by SPE purification. However, the concentrations of the adducts in clinical samples were still found to be below the LOD. Novel, reproducible, and accurate LC/MS/MS methods were developed for the determination of the urinary content of O(6)CMG and O(6)CMdG, and of the possible formation of O(6)MeG and O(6)MedG by decarboxylation. Clinical samples from volunteers on different diets were analysed. Further studies are required to discover a link between the presence of these biomarkers in urine and red meat consumption.

An improved genetically modified Escherichia coli biosensor for amperometric tetracycline measurement

The bacterial respiratory gene, nuoA, was previously used as a reporter gene in an amperometric, whole cell biosensor for tetracycline (Tet) detection. While the nuoA-based bioassay responded sensitively to Tet, the signal declined at high Tet concentrations, probably partly due to transgene over-expression. Also, at zero concentration of Tet, the assay registered a relatively high background signal when compared to the nuoA knockout Escherichia coli strain without the biosensor transgene construct. This was probably due to incomplete repression of nuoA expression. In order to reduce gene over-expression, the sensor cells were incubated with Tet at a relatively low temperature (15 °C). Also, a low-copy number plasmid pBR322 was used to carry the transgene, instead of the high-copy number plasmid pBluescript in order to reduce over-expression and to reduce background expression. Both assays improved the biosensor response. By using a low-copy number plasmid and tetracycline resistance, the sensor was less inhibited at higher Tet concentrations; but, this did not significantly increase the linear range of the sensor. The low temperature nuoA assay could detect Tet at a range of 0.001-1 μg ml(-1). In contrast, the low-copy number nuoA assay was able to detect Tet at a range of 0.0001-1 μg ml(-1). The detection limit of Tet determined by the low-copy number nuoA assay was 0.00023 μg ml(-1), which is one order of magnitude more sensitive than in the previous nuoA assay.

SU‐E‐T‐443: Measuring Prompt Gamma Emission During Passive Beam Proton Radiotherapy for Real Time Treatment Verification

Purpose: Recent studies demonstrate the feasibility of prompt‐gamma imaging for pencil beam proton therapy. In contrast to passive‐scatter proton radiotherapy, the existence of high background signal from secondary radiation produced by protons in the beam line components makes the detection of prompt‐gammas challenging. Our primary goal is to produce a more complete measurement of the prompt‐gammas produced in tissue for clinical treatment conditions. Methods: The proton treatment facility at iThemba Labs was studied in detail and all the nozzle components that interact with the proton beam were built and positioned at the locations specified by the manufacturer using the Geant4 Monte Carlo toolkit. The treatment nozzle was validated against depth dose and lateral profiles in a water phantom at therapeutic energies. The model included NaI detectors of different dimensions to detect the prompt‐gamma spectra, and standard gamma emitting sources in the energy range 0.661 to 4.438 MeV were used to determine the Gaussian broadening parameters of the detectors. Finally, prompt‐gamma spectra from the tissue phantom were simulated over a range of energies in order to make comparisons with the experimental spectra currently being measured. Results: The prompt‐gamma energy spectra show prominent peaks caused by collisions of proton with nuclei in the tissue phantom. Single and double escape peaks of 4.44 MeV were clearly seen, while the 6.129 MeV peak was unresolved due to the Doppler broadening effect, peaks at 6.916 and 7.115 MeV were not observed, but the single and double escape peaks of 6.129 MeV were visible. Conclusion: Our study confirms the feasibility of prompt‐gamma imaging during passive proton radiotherapy to assist for on‐line treatment verification. The energy range from 3.0 MeV to 5.0 MeV is a suitable candidate for further investigation and the presence of background radiation can be minimized by introducing proper shielding and collimation.

Short PEG-Linkers Improve the Performance of Targeted, Activatable Monoclonal Antibody-Indocyanine Green Optical Imaging Probes

The ability to switch optical imaging probes from the quenched (off) to the active state (on) has greatly improved target to background ratios. The optimal activation efficiency of an optical probe depends on complete quenching before activation and complete dequenching after activation. For instance, monoclonal antibody-indocyanine green (mAb-ICG) conjugates, which are promising agents for clinical translation, are normally quenched, but can be activated when bound to a cell surface receptor and internalized. However, the small fraction of commonly used ICG derivative (ICG-Sulfo-OSu) can bind noncovalently to its mAb and is, thus, gradually released from the mAb leading to relatively high background signal especially in the liver and the abdomen. In this study, we re-engineered a mAb-ICG conjugate, (Panitumumab-ICG) using bifunctional ICG derivatives (ICG-PEG4-Sulfo-OSu and ICG-PEG8-Sulfo-OSu) with short polyethylene glycol (PEG) linkers. Higher covalent binding (70-86%) was observed using the bifunctional ICG with short PEG linkers resulting in less in vivo noncovalent dissociation. Panitumumab-ICG conjugates with short PEG linkers were able to detect human epidermal growth factor receptor 1 (EGFR)-positive tumors with high tumor-to-background ratios (15.8 and 6.9 for EGFR positive tumor-to-negative tumor and tumor-to-liver ratios, respectively, at 3 d postinjection).